Jennifer L. McQuade

The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 29 papers. Top paper: “Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results”.

Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results

Nature Medicine(2023)10.1038/s41591-022-02170-x

N/A

1.9DataRank · unranked

83 citations

Sherise D. Ferguson, Roland L. Bassett, Alexandra P. Foster, Ida John, Tarin Hennegan +32 more

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9523

N/A

0.259DataRank · unranked

4 citations

Christopher P. Vellano, Miles C. Andrews, Russell G. Witt, Manoj Chelvanambi, Jennifer L. McQuade +15 more

Androgen receptor activity promotes resistance to BRAF-targeted melanoma therapy

Research Square(2020)10.21203/rs.3.rs-58480/v1

N/A

0DataRank · unranked

0 citations

Christopher P. Vellano, Michael White, Miles C. Andrews, Joseph R. Daniele, Mark Titus +41 more

Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

Nature Medicine(2021)10.1038/s41591-021-01406-6

N/A

0DataRank · unranked

424 citations

Connie P. M. Duong, Vancheswaran Gopalakrishnan, Valerio Iebba, W. S. Chen, Lisa Derosa +66 more

Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003277

N/A

0DataRank · unranked

118 citations

David M. Faleck, Anusha Shirwaikar Thomas, Jessica Harris, Deepika Satish, Xuemei Wang +13 more

Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002449

N/A

0DataRank · unranked

44 citations

Rodabe N. Amaria, Amer Najjar, Laszlo Radvanyi, Cara Haymaker, Marie-Andrée Forget +18 more

Clinical, molecular, metabolic, and immune features associated with oxidative phosphorylation in melanoma brain metastases

Neuro-Oncology Advances(2021)10.1093/noajnl/vdaa177

N/A

0DataRank · unranked

27 citations

Renato Guerrieri, Qianghua Hu, Aron Y. Joon, Swaminathan Kumar, Lauren E. Haydu +9 more

Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti‐CTLA4 and anti‐PD1 combination immunotherapy: Incidence, management, and clinical benefit

Cancer(2021)10.1002/cncr.34004

N/A

0DataRank · unranked

21 citations

Sahira Farooq, Macartney Welborn, Rodabe N. Amaria, Susan Y. Chon, Adi Diab +13 more

Identification of MicroRNA–mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes

Cancers(2021)10.3390/cancers13215301

N/A

0DataRank · unranked

12 citations

Michael G. White, Russell G. Witt, Anik Banerjee, Michael A. Davies, Guangchun Han +18 more

Neoadjuvant relatlimab and nivolumab in resectable melanoma

Nature(2022)10.1038/s41586-022-05368-8

N/A

0DataRank · unranked

339 citations

Michael A. Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos A. Torres‐Cabala +35 more

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

Nature(2022)10.1038/s41586-022-04833-8

N/A

0DataRank · unranked

130 citations

Michael G. White, Miles C. Andrews, Manoj Chelvanambi, Russell G. Witt, Joseph R. Daniele +60 more

Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2661

N/A

0DataRank · unranked

36 citations

Ashley V. Menk, Dayana B. Rivadeneira, Ryan C. Augustin, Mingchu Xu, Jun Li +47 more

Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-1060

N/A

0DataRank · unranked

17 citations

Yuzhong Jeff Meng, Marie‐Andrée Forget, Tatiana V. Karpinets, Katarzyna Tomczak, Chip Stewart +22 more

Gynecologic tract melanoma in the contemporary therapeutic era: High rates of local and distant disease progression

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.09.026

N/A

0DataRank · unranked

13 citations

Morgan A. Farr, Priyadharsini Nagarajan, Joel Ho, Andrew J. Bishop, Anuja Jhingran +7 more

Immune-related adverse events and symptom burden in patients with melanoma receiving adjuvant immune checkpoint inhibitor.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps12147

N/A

0DataRank · unranked

0 citations

Teresa Kuś, Salah-Eddine Bentebibel, Jennifer L. McQuade, Isabella Claudia Glitza, Rodabe N. Amaria +11 more

Melanoma and microbiota: Current understanding and future directions

Cancer Cell(2023)10.1016/j.ccell.2023.12.003

N/A

0DataRank · unranked

82 citations

Tanisha Jackson, Laura Mählmann, Christina K. Baumgartner, Martin J. Blaser, Allyson L. Byrd +26 more

Bodywide ecological interventions on cancer

Nature Medicine(2023)10.1038/s41591-022-02193-4

N/A

0DataRank · unranked

48 citations

Jennifer L. McQuade, Miriam Mérad, Fabrice Andre, Laurence Zitvogel, Guido Kroemer

Aerobic Exercise Alters the Melanoma Microenvironment and Modulates ERK5 S496 Phosphorylation

Cancer Immunology Research(2023)10.1158/2326-6066.cir-22-0465

N/A

0DataRank · unranked

27 citations

Sumedha Pareek, Jonghae Lee, Riccardo Ballarò, Darlan Conterno Minussi, Karma Hayek +12 more

Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia

Annals of Oncology(2023)10.1016/j.annonc.2023.06.007

N/A

0DataRank · unranked

13 citations

Joshua W.D. Tobin, Yongwoo David Seo, Georgina Gener‐Ricos, Emily Z. Keung, Elizabeth M. Burton +28 more

Stranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate Cancer

Endocrinology(2023)10.1210/endocr/bqad071

N/A

0DataRank · unranked

7 citations

Eleonora Dondossola, Kaitlin J. Basham, Nathaniel R. Wilson, Omar Alhalabi, Jianjun Gao +7 more

Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma

Nature(2023)10.1038/s41586-023-05892-1

N/A

0DataRank · unranked

2 citations

Michael A. Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos A. Torres‐Cabala +35 more

Rate of response to immune checkpoint inhibitor therapy in patients with conjunctival melanoma

Melanoma Research(2024)10.1097/cmr.0000000000001016

N/A

0DataRank · unranked

7 citations

Tyler Ogden, Matthew Nichols, Tracy Lu, J. Matthew Debnam, Florentia Dimitriou +3 more

Impact of COVID-19-related experiences on health-related quality of life in cancer survivors in the United States

PLoS ONE(2024)10.1371/journal.pone.0297077

N/A

0DataRank · unranked

4 citations

Sarah Prinsloo, Akina Natori, Richard W. Wagner, Telma Gomez, Jewel Ochoa +10 more

Development of a Strategic Initiative at MD Anderson Cancer Center to Improve Outcomes in Immune-Related Adverse Events

Journal of the National Comprehensive Cancer Network(2024)10.6004/jnccn.2023.7119

N/A

0DataRank · unranked

2 citations

Nicolas L. Palaskas, Bilal A. Siddiqui, Jennifer L. McQuade, Jamie S. Lin, Sumit K. Subudhi +8 more

Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanoma

OncoImmunology(2025)10.1080/2162402x.2025.2546402

N/A

0DataRank · unranked

5 citations

Simin Kiany, Marie‐Andrée Forget, Roland L. Bassett, Michael A. Davies, Adi Diab +15 more

Integrated analysis of molecular and clinical features associated with overall survival in melanoma patients with brain metastasis

Acta Neuropathologica Communications(2025)10.1186/s40478-025-01978-1

N/A

0DataRank · unranked

1 citations

Meredith S. Pelster, Merve Hasanov, Renato Guerrieri, Courtney W. Hudgens, Debora Alejandra Ledesma +19 more

The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell–Mediated Immunotherapies

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0430

N/A

0DataRank · unranked

166 citations

Snigdha Pramanik, Leila J. Williams, Hannah R. Hodges, Courtney W. Hudgens, Grant M. Fischer +11 more

Investigating Chronic Toxicity, Diet, Patient-Reported Outcomes and the Microbiome in Immunotherapy-Treated Metastatic Melanoma Survivors: A New Frontier

Nutrients(2025)10.3390/nu18010040

N/A

0DataRank · unranked

1 citations

Satabdi Saha, Nazli Dizman, Michelle Rohlfs, Elizabeth Sirmans, J. M. Gardner +17 more

Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker

Cancer Medicine(2020)10.1002/cam4.3474

N/A

0DataRank · unranked

16 citations

Fernando C. L. Carapeto, Aron Y. Joon, Lauren E. Haydu, Huiqin Chen, Fuchenchu Wang +13 more